Ceapro Inc and Angiogenesis Foundation Inc at Virtual Investor: Summer Spotlight Series Transcript

Jul 12, 2023 / 05:00PM GMT
Jenene Thomas - JTC Team, LLC - Moderator

Well, good afternoon, and thank you for joining us for our next company in the Virtual Investor Summer Spotlight Series. We are on day two. We've had an action-packed schedule and we have an exciting company, Ceapro Inc., going to be sort of the discussion next.

So my name is Jenene Thomas, I am CEO of JTC IR, and I will be the moderator for today's event. I am pleased to be joined by Gilles Gagnon, Chief Executive Officer of Ceapro; and Dr. Vincent Lee, Chief Operating Officer and Scientific Director of The Angiogenesis Foundation.

So before we get started, I want to inform our audience that Ceapro is publicly listed and trades on the TSX-V under the ticker CZO and the OTCQX under the ticker CRPOF. So during today's discussion, the company will be making forward-looking statements, and I encourage everyone to view the company's website at ceapro.com for the latest information. Gilles, Dr. Li, welcome. So happy to have you on our conference.

Gilles Gagnon - Ceapro Inc. - President & CEO

Thank you,

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot